Tuesday, December 31, 2013

Pharmaceutics Department Pharmaceutical Dosage Forms (1)


Pharmaceutics Department

Pharmaceutical Dosage Forms (1)

List of Contents:-
Introduction (The composition of suspension)
Formulation of Pharmaceutical Suspensions
Requirements of pesticide active ingredients and solvent
The fundamental characteristics of suspended emulsions
The fundamental characteristics of suspended emulsions
Critical micelle concentration
The physical stability of the suspended emulsion
The advantages and disadvantages of Suspended Emulsion
The choice of surfactant
Physical properties of a well-formulated suspension
Features Desired In Pharmaceutical Suspensions
Stability
Packing
Pharmaceutical applications of suspensions
As oral DDS
Suspensions for Topical administration
Suspensions for parenteral use
Reconstitutable suspensions
Suspensions for inhalation
Conclusion
Reference List
Introduction:-
The composition of suspension

Suspension-emulsion is a new formulation, which allows the greatest possible to put several incompatible active ingredients combined to a single formulation. In particular, one or several water-insoluble liquid pesticide active ingredient (or low melting point pesticide active ingredient in the solvent mixture) mix with another one or several water-insoluble solid pesticide active ingredient, with water as medium, relying on surface-active agent processed into a stable suspended emulsion formulations. The most popular formulation is prepared by two different active ingredients in pesticides (ie, a water-insoluble liquid pesticide active ingredients and the other a water-insoluble solid pesticide active ingredients) combined to suspended emulsion. Such formulations are generally composed by three-phase:
1-solid dispersed and suspended particles form the suspended phase
2-liquid emulsion oil droplets form the emulsion phase
3-water is the continuous phase. Accordingly, the dispersed oil phase of emulsion can be composed by different forms, either by the containing no active ingredient emulsion (for example, containing only mineral oil or vegetable oil, etc.), or by the containing active ingredients EC or oil in water of emulsion (micro-emulsion and water emulsion), which can obtain various forms of suspended emulsion. If there is a water-soluble pesticide active ingredient (eg, Glyphosate) adding to the aqueous phase, may also constitute another mixing suspended emulsion.
Surface Active Agents form a unique class of chemical compounds. This review provides anintroduction to the nature and physical properties of surfactants, emphasizing theirability to radically alter surface and interfacial properties and to self-associate andsolubilize themselves in micelles. These properties provide the means to applysurfactants in wettability modification, detergency, and the displacement of liquidphases through porous media on one hand, and to stabilize dispersions (includingfoams, froths and emulsions), or to destabilize dispersions (again including foamsand emulsions) on the other hand. These in turn lead to a vast array of practicalapplication areas which are illustrated in terms of mineral and petroleum processing,biological systems, health and personal care products, foods, and crop protection.The surfactant industry is dominated by several types: alkylbenzene sulfonatesalcohol ethoxylates, sulfates and ethersulfates These are the major components oflaundry detergents, household, and personal care products and account for over halfof all use of surfactants. Interest in increasing performance in these areas has also ledto research into mixed surfactant systems. Other commercial interests have also influencedthe developments in surfactant science.

Formulation of Pharmaceutical Suspensions
For the need of a stable suspension, the term ‘Structured vehicle’ is most important for formulation view and stability criteria. The main disadvantage of suspension dosage form that limits its use in the routine practice is its stability during storage for a long time. To overcome this problem or to reduce it to some extent, the term ‘Structured vehicle has got importance
What do you mean by Structured Vehicle?

The structured vehicle is the vehicle in which viscosity of the preparation under the static condition of
very low shear on storage approaches infinity. The vehicle behaves like a ‘false body’, which is able to maintain the particles suspended which is more
or less stable
Let it be clear that ‘Structured
vehicle’ concept is applicable only to deflocculated suspensions, where hard solid cake forms due to settling of solid particles and they must be redispersed
easily and uniformly at the time of administration. The Structured Vehicle concept is not applicable to flocculated suspension because settled floccules get easily redispersed on shaking
Generally, concept of Structured vehicle is not useful for Parenteral suspension because they may create problem in syringeability due to high viscosity
In addition, Structured vehicle should possess some degree of Thixotropic behaviour viz., the property of GEL-SOL-GEL transformation. Because during storage it should be remained in the form of GEL to overcome the shear stress and to prevent or reduce the formation of hard cake at the bottom which to some extent is beneficial for pourability and uniform dose at the time of administration

Preparation Of Structured Vehicle
Structured vehicles are prepared with the help of Hydrocolloids. In a particular medium, they first hydrolyzed
and swell to great degree and increase viscosity at the lower concentration. In addition, it can act as a ‘Protective colloid’ and stabilize charge.
Density of structured vehicle also can be increased by;
PolyvinylpyrrolidonePolyethylene glycols
Glycerin Sugars
Requirements of pesticide active ingredients and solvent :-
1-Solid and liquid active ingredients in pesticides must be insoluble or low-solubility in the water (solubility of pesticide active ingredient in water, generally at the 0 ~ 40 condition, preferably less than 500 mg / L. If the solubility in water is too large, then there is more difficulties to get a stable suspend emulsion formulation.)

2-Solid pesticide active ingredients must not intersoluble with the liquid pesticide active ingredient (or low melting point pesticide active ingredient in the solvent mixture), otherwise the suspend emulsion formulation can not be obtaind.
3-Better to use liquid pesticide active ingredients, reducing the low melting point pesticide active ingredient in solvent mixture.
4-Pesticide active ingredients in the chemical are stable (without decomposition in water).
The factors must be considered in the selection of solvent or solvent system are
1-The active ingredients of the pesticide have an excellent solubility
22-The solvent should not dissolve in water or a low solubility in water (at least less than 0.1%). The solution obtaind should be stable during the production and storage at all the temperatures (no crystallization).
3- The solvent has a high flash point to ensure itssafety during oil phase preparation.

The fundamental characteristics of suspended emulsions :-
It is very important to provide a stable solid dispersion in the suspended emulsion. But when produce a stable emulsion using various methods, the most complicating factor is how to make a stable emulsion phase. The emulsion phase is unstable thermodynamically system, so there are a lot of work around how to get non-flocculating or avoid emulsion phase oil-based competition in the solid dispersions to obtain a stable emulsion phase. Usually the most used emulsion during processing is oil in water emulsion (EW) emulsion phase. Therefore, someone view the formulation as a combination of suspended emulsion SC (SC) and water emulsions (EW) formulations. It should be noted that simply mixing SC and EW formulations usually do not obtain a stable suspension emulsion, because the surfactant (emulsifier and dispersing agent) cannot achieve a right balance system, which may lead surfactant preferential adsorption on the surface of oil droplets or dispersed particle surface so that will also cause flocculation miscellaneous problems, resulting in suspension-emulsion instability.

Critical micelle concentration

Surface active agent physico-chemical properties
The physico-chemical properties of surfactants vary
markedly above and below the cmc value.2–8,12,13,16,19,51,67–69,74–82 Below the cmc value,the physico-chemical properties of ionic surfactants like sodium dodecyl sulfate, SDS,e.g., conductivities, electromotive force measurements) resemble those of a strongelectrolyte. Above the cmc value, these properties change dramatically, indicating ahighly cooperative association process is taking place. This is illustrated by Preston’s 83 classic graph,The cmc is also of interest because at concentrations above this value the adsorptionof surfactant at interfaces usually increases very little. That is, the cmc frequentlyrepresents the solution concentration of surfactant from which nearly maximumadsorption occurs

The general way of obtaining the cmc value of a surfactant micelle is to plot anappropriate physico-chemical property versus the surfactant concentration andobserve the break in the plot.
The physical stability of the suspended emulsion

How to solve the physical stability of the suspended emulsion during storage is a very important issue, but also is the main problems of restricting the development and production of the formulation. During storage especially in the higher temperatures the formulation exist instability: stratification and sedimentation; separation of solid particles and oil droplets; oil droplets coalescence; flocculation of solid particles and oil droplets; larger of the solid particles and oil droplets crystallization (ie, Ostwald ripening); phase transfer. It is very difficult to get the best suspension emulsion product. Because not only have to consider two separate formulations (suspension agent and emulsion phase) may be unstable issues, such as egation as well as poly-and, Ostwald ripening that is the crystallization of particles and droplets growing up, hierarchical, milk analysis or deposition, etc. The so-called mixing flocculation is the flocculation between solid particles and oil droplets, when a combination of the two dispersion phase. In other words, when one solid particle is wetted by another oil droplet, the surface-active agent may be consumed in oil - water interface; if the solid particle is wetted by several oil droplets, the emulsion coalescence may occur. As the solid particles plays a catalytic role, which can also accelerate the speed of emulsion coalescence, ultimately lead to formulation instability.


The advantages and disadvantages of Suspended Emulsion:-


Suspended Emulsion combine solid and liquid pesticide active ingredients in the same formulation. The biological effectiveness can complete and expand prevention and treatment spectrum. Exempt tank mix incompatibility and improve efficiency. With water as the medium, it is safe to the operator and user, favorable to environmental protection and cost savings, reducing skin and eye irritation and toxicity, fewer solvents and avoiding the production of flammable, explosive and toxic issues. It is easy to use, and low cost of package, storage and transportation, reducing spray frequency. But it also has some disadvantages, such as more difficulty to develop high-quality stable formulations, very high technical requirements for processing and sometimes use high-shear, homogeneous and other special equipment. There are still packager washing and treatment problems.
The choice of surfactant:-
Surface-active agents (emulsifiers, wetting agent and dispersing agent) are fundamental components of the suspended emulsion, which plays an important role of stability during the preparation of formulation and long-term storage.
The role of emulsifiers include
1-Lowering the oil / water surface tension, so that the oil phase emulsify and disperse in the aqueous phase

2-provide the electrostatic and space stability between oil droplets (preventing flocculation, cohesion and coalescence
3-Improve the compatibility of emulsion and suspension solution in state of concentrated and diluted
The roles of wetting agent / dispersing agent includes
1-wet the particle surface of solid active ingredients
2-help wet grinding
3-allow solid particles to disperse in the continuous phase
4-improve the compatibility of suspension at the state of concentration and dilution.
The surface-active agents used in suspended emulsion generally selecte the emulsifier and dispersing agents used in the preparation of SC and EW formulations. The emulsifiers commonly used are alkyl benzene sulfonates, alkyl phenol polyoxyethylene ether, styrene phenol polyoxyethylene ether, polyol fatty acid esters and their polyoxyethylene adduct etc., while nonionic or anionic compound are used widespread. The dispersants commonly used are lignin sulfonate, alkyl naphthalene sulfonate formaldehyde condensate, alkyl aryl polyoxyethylene ether and its phosphate or salt, and EO / PO block copolymer and so on.
However, to obtain high-quality suspension emulsion, we can choose a non-reversible adsorption of the polymer surfactant, such as comb-type copolymers. It is firmly adsorbed on the surface of solid particles and will not de-absorption and transfer, so that establish a stable dispersion system and avoid flocculation problems produced in suspension emulsions, obtaining a stable suspension emulsion. With a silicon of the polymerizable surfactant to stabilize the O / W emulsion, it can also be a stable suspension emulsion, which is at the surface of oil droplets exist strong surface anchoring and strong space exclusion. Wetting solid particles effective protected are unlikely to occur. At this time, it will not contribute to the coalescence of emulsion and can get a stable suspension emulsion. In addition, PEO comb – type and block copolymer used in the hanging emulsion, it is useful for the stability of the composition of the suspended solids particles
Physical properties of a well-formulated suspension :-
-Remain sufficiently homogenous at least at period of shaking the container & removing the required dose
Sediment formed on storage must be easily resuspended by moderate shaking-
Viscosity must not be so high so to be easily removed & applied-
-Suspended particles must be small & with uniform size to have smooth & elegant product
Features Desired In Pharmaceutical Suspensions
 The suspended particles should not settle rapidly and sediment produced, must be
easily re-suspended by the use of moderate amount of shaking.
It should be easy to pour yet not watery and no grittiness.

It should have pleasing odour, colour and palatability.
Good syringeability.
It should be physically,
chemically and microbiologically stable.
Parenteral/Ophthalmic
suspension should be sterilizable


STABILITY

One area that has presented a number of problems includes the assurance of stability of oral liquid products throughout their expiry period. For example, there have been a number of recalls of the vitamins with fluoride oral liquid products because of vitamin degradation. Drugs in the phenothiazine class, such as perphenazine, chlorpromazine and promethazine have also shown evidence of instability. Good practice for this class of drug products would include quantitation of both the active and primary degradant. Dosage form manufacturers should know and have specifications for the primary degradant. Review the firm's data and validation data for methods used to quantitate both the active drug and degradant

Because interactions of products with closure systems are possible, liquids and suspensions undergoing stability studies should be stored on their side or inverted in order to determine whether contact of the drug product with the closure system affects product integrity
Moisture loss which can cause the remaining contents to become superpotent and microbiological contamination are other problems associated with inadequate closure systems

PACKAGING

Problems in the packaging of oral liquids have included potency (fill) of unit dose products, accurate calibration of measuring devices such as droppers that are often provided. The USP does not provide for dose uniformity testing for oral solutions. Thus, for unit dose solution products, they should deliver the label claim within the limits described in the USP. Review the firm's data to assure uniformity of fill and test procedures to assure that unit dose samples are being tested.

Another problem in the packaging of Oral Liquids is the lack of cleanliness of containers prior to filling. Fibers and even insects have been identified as debris in containers, and particularly plastic containers used for these products. Many manufacturers receive containers shrink-wrapped in plastic to minimize contamination from fiberboard cartons. Many manufacturers utilize compressed air to clean containers. Vapors, such as oil vapors, from the compressed air have occasionally been found to present problems. Review the firm's systems for the cleaning of containers.

Pharmaceutical applications of suspensions :-

As oral DDS
Useful for people having difficulty in swallowing solid dosage forms
Useful for drugs that are required to be in a finely divided form in the GIT to poses high surface area.  E.g. Kaolin, magnesium carbonate& trisilicate to adsorb toxins
Highly palatable & so suitable for children. E.g.  Paracetamol is available both in solution and as suspension, suspension is more palatable for children

E.g. Vibramycin® Monohydrate(doxycycline monohydrate) for Oral Suspension


Vibramycin is an antibacterial drug synthetically derived from oxytetracycline, and is available as Vibramycin Monohydrate (doxycycline monohydrate); Vibramycin Hyclate and Vibra-Tabs (doxycycline hydrochloride hemiethanolate hemihydrate) and Vibramycin Calcium (doxycycline calcium) for oral administration

Suspensions for Topical administration
They can be fluid preparations, e.g. Calamine lotion
Or semisolid preparations with high conc. Of powder dispersed usually in a paraffin base, e.g. pastes
Also powdered drug may be suspended in an emulsion base, e.g. Zinc cream

Taclonex (calcipotriene hydrate and betamethasone propionate) for Topic adm®E.g.
Apply Taclonex® Topical Suspension to affected areas once daily for up to 8 weeks. Treatment may be discontinued earlier, if cleared

. Instruct patients not to exceed a maximum weekly dose of 100 g
Instruct patients to shake bottle prior to using Taclonex® Topical Suspension and to wash their hands after applying the product
Taclonex® Topical Suspension is not for oral, ophthalmic, or intravaginal use.

Suspensions for parenteral use
Useful in controlling the rate of drug absorption
Useful in controlling the duration of activity by varying the size of dispersed particles of the drug
If the drug is suspended in a Fixed oil such as arachis or sesame, the drug will remain after injection in the form of drug depot (the release of drug from aqueous vehicle will be faster.

E.g. ®Methylprednisolone acetate injectable suspension
is an anti-inflammatory glucocorticoid for intramuscular, intra-articular, soft tissue or intralesional injection. It is available as single-dose vials in two strengths: 40 mg/mL; 80 mg/mLethylprednisolone acetate injectable suspension USP contains methylprednisolone acetate USP which is the 6-methyl derivative of prednisolone. Methylprednisolone acetate USP is a white or practically white, odorless, crystalline powder which melts at about 215° with some decomposition. It is soluble in dioxane, sparingly soluble in acetone, in alcohol, in chloroform, and in methanol, and slightly soluble in ether.


Reconstitutable suspensions
reach user as a mixture of dry powders dispersed in vehicle (usually water) i.e., reconstituted immediately before use
- Once reconstituted, they have limited shelf-lives (weeks)
- Used for unstable drugs
E.g. Dry powder of pediatric antibiotics can stay for long shelf-life, but when formulated as suspension used for 15 days

Drug resinate 12.0 gXanthan gum 0.2 gAvicel RC591** 1.5 gSodium saccharin 0.3 gSorbic acid 0.2 gSodium methyl hydroxyl benzoate 0.12 gSodium propyl hydroxyl benzoate 0.08 gPeppermint flavor 0.5 gTitanium dioxide 0.2 gSorbitol powder 20 g______________________________________ *containing 25% w/w ranitidine base equivalent **mixture of 89% w/w microcrystalline cellulose and 11% w/w sodium carboxymethylcellulose
All the powders were blended together using a suitable mixer for subsequent filling into a 150 ml bottle. At the time of dispensing, 80 ml of potable water is added and the mixture shaken to give 100 ml of suspension containing 150 mg ranitidine base equivalent per 5 ml

Suspensions for inhalation
Suitable for drugs unstable in GIT
To give rapid therapeutic effect

E.g. ®Budesonide suspension for nebulizer – inhalation
It is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. This medication belongs to a class of drugs known as corticosteroids. It works directly in the lungs to make breathing easier by reducing the irritation and swelling of the airways.This medication must be used regularly to be effective. It does not work immediately and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler as prescribed.OTHER This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This medication may also be used to treat lung diseases such as bronchitis and emphysema..
Summarize for General Application of suspensions
Suspension is usually applicable for drug which is insoluble or poorly soluble.
E.g Prednisolone suspension
To prevent degradation of drug or to improve stability of drug
E.g. Oxytetracycline suspension
To mask the taste of bitter of unpleasant drug
E.g. Chloramphenicol palmitate suspension
Suspension of drug can be formulated for topical application e.g. Calamine lotion
Suspension can be formulated for parenteral application in order to control rate of drugabsorption
Vaccines as a immunizing agent are often formulated as suspension
E.g. Cholera vaccine
X-ray contrast agent are also formulated as suspension
E.g. Barium sulphate for examination of alimentary tract
Summary

A Pharmaceutical suspension is a coarse dispersion in which internal phase is dispersed uniformly throughout the external phase.
The internal phase consisting of insoluble solid particles having a specific range of size which is maintained uniformly through
out the suspending vehicle with aid of single or combination of suspending agent.
The external phase (suspending medium) is generally aqueous in some instance, may be an organic or oily liquid for non oral use.
Suspension dosage form is a preferred and widely accepted dosage forms for insoluble or poorly soluble drugs for various therapeutic applications. The suspension dosage form has long been used for insoluble and poorly soluble drugs for making oral, topical and parenteral products. Pharmaceutical Suspensions, From Formulation Development to Manufacturing provides the reader with a broad overview of suspension drug product technology. Individual chapters in this book focus on suspension formulation principles, excipients, analysis, pharmaceutical development, preclinical, clinical and regulatory aspects, as well as the emerging technology of nanosuspensions as nanomedicine. Various chapters in the book are written by authors from academia, regulatory agencies and industries who are experts in their respective fields. The book includes over 600 bibliographic citations, numerous tables and illustrations.
Pharmaceutical Suspensions is the only volume to date that systematically follows the suspension dosage development approach used widely in the pharmaceutical industries starting with pre-formulation/formulation development, pre-clinical evaluation and critical characterization method development, continuing to clinical trial essentials and ending with technology transfer essentials and regulatory filing guidance.






References :-

Book References:-
-MSA Pharmaceutical Dosage Form 1 Book
-Laurier L. Schramm,*a,b Elaine N. Stasiuk b   and D. Gerrard Marangoni c (Surfactants and their applications)
-R. Leung, M. Jeng Hou and D. O. Shah, in Surfactants in Chemical/Process Engineering, ed. D. T. Wasan,
M. E. Ginn and D. O. Shah, Marcel Dekker, Suspension relation with SAA New York, 1988, p. 315-
Web References
2-
3-
4-
5-
6-
7-

Share

Twitter Delicious Facebook Digg Stumbleupon Favorites